Pharmaceutical

Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera

Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera

articlePerseus Proteomics, Inc.July 1, 20265/news/notice-regarding-the-results-of-a-clinical-study-in-patients-who-participated-in-the-phase-i-clinical-trial-of-ppmx-t003-for-polycythemia-vera
Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera

About this update from Perseus Proteomics, Inc.

Perseus Proteomics, Inc. (4882) Press ReleaseView Attachment

View stock analysis, news, and events for Perseus Proteomics, Inc.